As a transcription factor, c‐Myc has been reported to regulate the transcription of numerous genes, including mutant TP53 in pancreatic cancer, lymphoma and so on,[62, 63] but the effect of c‐Myc on mutant TP53 transcription in breast cancer has not been well studied. This evidence concerns the gene TP53 and familial pancreatic carcinoma.